Market Valuation: Immunic Inc (IMUX)
The market trend for Immunic, Inc. (IMUX) shown on this price chart reflects the dynamics of a company whose production base relies on third-party plants, which is offset by strict control and contracts. The current indicator is 0.11. The business has earned pricing power by developing selective tablets for multiple sclerosis therapy. Such convenient delivery formats replace injections, ensuring rapid growth of its share in the immunology segment.
Comprehensive metric breakdowns and analytics for immunic-therapeutics.com (IMUX)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Immunic, Inc.|IMUX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Immunic|IMUX - Company Aggregate Debts|Debt to Book Capitalization Ratio IMUX|IMUX - Company Long-Term Loans and Borrowings|Company Short-Term Debt Immunic|Quick Ratio immunic-therapeutics.com
- net income and valuation multiples indicators:
IMUX - Net Profit|Future Profit Immunic, Inc.|IMUX - Company Value to Net Income|Forward P/E Multiple Immunic|IMUX - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IMUX|IMUX - Operating profit before deduction of amortization|Earnings per share for the last twelve months Immunic|IMUX - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months immunic-therapeutics.com|IMUX - Earnings growth in current year|Net earnings per share growth forecast for next year Immunic, Inc.
Fundamental company analysis:IMUX (Immunic Inc)
The non-cyclical nature of multiple sclerosis drug development provides Immunic, Inc. (IMUX) with high macro-resilience. Market capitalization measures the aggregate value of all shares, reflecting the current market valuation of the business. This indicator allows an investor to compare the company's actual value with its liquid reserves. Analyzing the dynamics helps filter out volatile noise from the long-term trend. The market capitalization of a public company on this chart captures the objective value of assets.
Key competitors
Market Value argenx ARGX|BNTX - Market Valuation|ABVX: Market Valuation|ADMA - Market Capitalization|PTGX (Protagonist Therapeutics) - Market Valuation|Market Capitalization IMVT|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Market Capitalization|Market Capitalization ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Market Value|RAPT Therapeutics - Market Capitalization|Market Capitalization Aerovate Therapeutics Inc JBIO|Aclaris Therapeutics (ACRS) - Market Value|Market Valuation kyvernatx.com|Market Value Tiziana Life Sciences Ltd|Market Valuation Cabaletta Bio Inc. (CABA)|Market Valuation VTYX (Ventyx Bio)|Market Capitalization Theratechnologies, Inc (THTX)|Market Value Avalo Therapeutics, Inc AVTX|ELDN: Market Capitalization|Agenus Inc. - Market Capitalization|Market Capitalization Climb Bio Inc. CLYM|ZURA: Market Capitalization|Market Valuation aTyr Pharmaceuticals|Market Valuation ADAG|IMA: Market Value|Market Capitalization STTK|Market Capitalization equilliumbio.com|Market Value Connect Biopharma Holdings Limited CNTB|ATRA: Market Capitalization|InflaRx GmbH - Market Capitalization|x4pharma.com (XFOR) - Market Valuation|ACET (adicetbio.com) - Market Valuation|CELU - Market Capitalization|INMB (INmune Bio Corp) - Market Capitalization|Barinthus Biotherapeutics Corp (BRNS) - Market Capitalization|Market Value Kezar Life Sciences (KZR)|Market Valuation sabbiotherapeutics.com SABS|Akari Therapeutics Plc - Market Valuation|Market Capitalization Enlivex Therapeutics Ltd ENLV|QTTB: Market Valuation|GOVX (GeoVax Corp) - Market Capitalization|Edesa Biotech, Inc. (EDSA) - Market Value|Market Valuation IBIO (ibioinc.com)|CARM (Carisma Therapeutics Inc) - Market Capitalization|XTLB: Market Value|Market Capitalization BOLT|Market Capitalization hcwbiologics.com (HCWB)|Market Value Aptevo Therapeutics Inc. APVO|Market Value AIM|ADTX - Market Value|GRI Bio Inc (GRI) - Market Valuation|XRTX: Market Capitalization|Vyome Therapeutics (HIND) - Market Capitalization|Market Valuation REVB|INDP: Market Value|Market Capitalization SCNI|Market Capitalization calcimedica.com|Market Value Affimed N.V. AFMD|ALLK - Market Valuation|HOOK - Market Value|IGM Biosciences, Inc. (IGMS) - Market Valuation|ITOS (iTeos Therapeutics, Inc.) - Market Valuation|Ocean Biomedical Inc (OCEA) - Market Capitalization|Market Value TC BioPharm (Holdings) PLC|Market Capitalization THRD (Third Harmonic Bio Inc)
